Mario Cazzola Mario Cazzola is an Honorary Professor of Respiratory Medicine at the University of Rome “Tor Vergata” (Rome, Italy) and at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences (London, UK). Mario’s research mainly focuses on the pharmacology of airway diseases, particularly the use of bronchodilators. According to Expertscape (February 2020), he is the top-rated expert in COPD and in bronchodilator agents in the world. Mario is Chairman of the Southern Europe Chapter of Interasma and Chairman of the Med COPD Forum. He was previously: Chairman of the Airway Pharmacology and Treatment Group of the European Respiratory Society (ERS) Secretary of the Inflammatory Airway Diseases and Clinical Allergy Assembly of ERS ERS Postgraduate Courses Director an Internal Auditor at ERS a member of the Steering Committee of the Airway Disorders Network and a Governor of the Italian Chapter of the American College of Chest Physicians. Mario was Co-Chair of the ERS/American Thoracic Society (ATS) Task Force “Outcomes for COPD pharmacological trials: from lung function to biomarkers”. He is a Fellow of ERS and in 2015, received a Lifetime Achievement Award from the same society. He has acted as referee/assessor for different universities and agencies worldwide. Mario founded Therapeutic Advances in Respiratory Diseases and served as its first Editor-in-Chief. He has also held the position of Editor-in-Chief of Pulmonary Pharmacology and Therapeutics, and COPD Research and Practice. He serves as an Associate Editor for Respiratory Medicine, Respiratory Research, Current Research in Pharmacology and Drug Discovery, Clinical Investigation and The Open Respiratory Medicine Journal. He is the author/co-author of almost 670 scientific papers. His H-index is 62. x
Previous Page Next Page